spacer
spacer

PDBsum entry 6cs2

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Viral protein/hydrolase PDB id
6cs2

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
891 a.a.
1076 a.a.
544 a.a.
Ligands
NAG-NAG-BMA ×9
NAG-NAG ×7
NAG-NAG-BMA-MAN ×11
NAG ×6
PDB id:
6cs2
Name: Viral protein/hydrolase
Title: Sars spike glycoprotein - human ace2 complex, stabilized variant, all ace2-bound particles
Structure: Spike glycoprotein,fibritin. Chain: a, b, c. Synonym: s glycoprotein,e2,peplomer protein. Engineered: yes. Mutation: yes. Angiotensin-converting enzyme 2. Chain: d. Synonym: ace-related carboxypeptidase,angiotensin-converting enzyme homolog,aceh,metalloprotease mprot15.
Source: Human sars coronavirus, enterobacteria phage t4. Sars-cov, bacteriophage t4. Organism_taxid: 227859, 10665. Gene: s, 2, wac, t4tp161. Expressed in: homo sapiens. Expression_system_taxid: 9606. Expression_system_cell_line: hek293f. Homo sapiens.
Authors: R.N.Kirchdoerfer,N.Wang,J.Pallesen,H.L.Turner,C.A.Cottrell, J.S.Mclellan,A.B.Ward
Key ref: R.N.Kirchdoerfer et al. (2018). Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis. Sci Rep, 8, 15701. PubMed id: 30356097
Date:
19-Mar-18     Release date:   11-Apr-18    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P10104  (WAC_BPT4) -  Fibritin from Enterobacteria phage T4
Seq:
Struc:
 
Seq:
Struc:
487 a.a.
891 a.a.*
Protein chains
Pfam   ArchSchema ?
P59594  (SPIKE_CVHSA) -  Spike glycoprotein from Severe acute respiratory syndrome coronavirus
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1255 a.a.
891 a.a.*
Protein chain
Pfam   ArchSchema ?
P10104  (WAC_BPT4) -  Fibritin from Enterobacteria phage T4
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
487 a.a.
1076 a.a.*
Protein chain
Pfam   ArchSchema ?
P59594  (SPIKE_CVHSA) -  Spike glycoprotein from Severe acute respiratory syndrome coronavirus
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1255 a.a.
1076 a.a.*
Protein chain
Pfam   ArchSchema ?
Q9BYF1  (ACE2_HUMAN) -  Angiotensin-converting enzyme 2 from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
805 a.a.
544 a.a.
Key:    PfamA domain  Secondary structure
* PDB and UniProt seqs differ at 868 residue positions (black crosses)

 Enzyme reactions 
   Enzyme class 1: Chain D: E.C.3.4.17.-  - ?????
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
   Enzyme class 2: Chain D: E.C.3.4.17.23  - angiotensin-converting enzyme 2.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: angiotensin II + H2O = angiotensin-1-7 + L-phenylalanine
angiotensin II
+ H2O
= angiotensin-(1-7)
+
L-phenylalanine
Bound ligand (Het Group name = NAG)
matches with 44.44% similarity
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    Added reference    
 
 
Sci Rep 8:15701 (2018)
PubMed id: 30356097  
 
 
Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis.
R.N.Kirchdoerfer, N.Wang, J.Pallesen, D.Wrapp, H.L.Turner, C.A.Cottrell, K.S.Corbett, B.S.Graham, J.S.McLellan, A.B.Ward.
 
  ABSTRACT  
 
Severe acute respiratory syndrome coronavirus (SARS-CoV) emerged in 2002 as a highly transmissible pathogenic human betacoronavirus. The viral spike glycoprotein (S) utilizes angiotensin-converting enzyme 2 (ACE2) as a host protein receptor and mediates fusion of the viral and host membranes, making S essential to viral entry into host cells and host species tropism. As SARS-CoV enters host cells, the viral S is believed to undergo a number of conformational transitions as it is cleaved by host proteases and binds to host receptors. We recently developed stabilizing mutations for coronavirus spikes that prevent the transition from the pre-fusion to post-fusion states. Here, we present cryo-EM analyses of a stabilized trimeric SARS-CoV S, as well as the trypsin-cleaved, stabilized S, and its interactions with ACE2. Neither binding to ACE2 nor cleavage by trypsin at the S1/S2 cleavage site impart large conformational changes within stabilized SARS-CoV S or expose the secondary cleavage site, S2'.
 

 

spacer

spacer